Table 1 Demographic data of RTW group and non-RTW group in the 5th year.
Variable | ALL | RTW | nonRTW |
|---|---|---|---|
136,342 | 69,619 (51.1%) | 66,723 (48.9^) | |
Age (year) mean ± SD | 49.8 ± 9.8 | 47.6 ± 9.4 | 52.1 ± 9.7 |
Gender | 63,247 | 23,169 (33.3%) | 40,078 (60.1%) |
Comorbidity | |||
Disorders of lipoid metabolism | 11,997 | 5706 (8.2%) | 6291 (9.4%) |
Obesity | 353 | 200 (0.3%) | 153 (0.2%) |
Alcohol abuse | 2466 | 493 (0.7%) | 1973 (2.9%) |
Hypertension | 24,741 | 10,566 (15.2%) | 14,175 (21.2%) |
Myocardial infarction | 364 | 125 (0.2%) | 239 (0.3%) |
Congestive heart failure | 1959 | 623 (0.9%) | 1336 (2.0%) |
Peripheral vascular disease | 1070 | 440 (0.6%) | 630 (0.9%) |
Cerebrovascular disease | 3261 | 1037 (1.5%) | 2224 (3.3%) |
Dementia | 194 | 38 (0.1%) | 156 (0.2%) |
Chronic pulmonary disease | 7276 | 2605 (3.7%) | 4671 (7.0%) |
Rheumatologic disease | 1394 | 746 (1.1%) | 648 (1.0%) |
Peptic ulcer disease | 15,514 | 5997 (8.6%) | 9517 (14.3%) |
Mild liver disease | 19,189 | 6919 (10.0%) | 12,270 (18.4%) |
Hemiplegia or paraplegia | 327 | 100 (0.1%) | 227 (0.3%) |
Renal disease | 3117 | 1133 (1.6%) | 1984 (2.9%) |
Moderate or severe liver disease | 1600 | 262 (0.4%) | 1338 (2.0%) |
Psychoses | 667 | 253 (0.4%) | 414 (0.6%) |
Depression | 3307 | 1597 (2.3%) | 1710 (2.6%) |
Treatment | |||
Operation | 65,154 | 40,750 (76.5%) | 24,404 (47.7%) |
Radiotherapy | 24,378 | 11,989 (22.6%) | 12,389 (24.2%) |
Chemotherapy | 31,896 | 13,014 (24.6%) | 18,882 (36.9%) |
Hormone therapy | 10,797 | 7333 (13.8%) | 3464 (6.8%) |
Working district | |||
Central | 27,919 | 14,316 (20.6%) | 13,603 (20.4%) |
North | 67,119 | 34,784 (50.0%) | 32,335 (48.4%) |
East | 2788 | 1279 (1.8%) | 1509 (2.3%) |
South | 38,222 | 19,085 (27.4%) | 19,137 (28.7%) |
Islands | 294 | 155 (0.2%) | 139 (0.2%) |
Income range | |||
≤ 28,800 | 84,430 | 46,600 (66.9%) | 37,830 (56.7%) |
> 28,000–38,200 | 21,308 | 11,703 (16.8%) | 9605 (14.4%) |
> 38,200 | 30,604 | 11,316 (16.3%) | 19,288 (28.9%) |
Industrial classification | |||
Agriculture, Forestry, Fishing and Husbandry | 9566 | 4760 (6.8%) | 4806 (7.2%) |
Mining and Quarrying | 98 | 37 (0.1%) | 61 (0.1%) |
Manufacturing | 42,511 | 21,936 (31.5%) | 20,575 (30.8%) |
Electricity and Gas Supply | 451 | 146 (0.2%) | 305 (0.4%) |
Water Supply and Remediation Activities | 891 | 349 (0.5%) | 542 (0.8%) |
Construction | 15,464 | 6972 (10.0%) | 8492 (12.7%) |
Wholesale and Retail Trade | 16,656 | 8677 (12.4%) | 7979 (11.9%) |
Transportation and Storage | 9362 | 4203 (6.0%) | 5159 (7.7%) |
Accommodation and Food Service Activities | 5527 | 2965 (4.2%) | 2562 (3.8%) |
Information and Communication | 2033 | 1050 (1.5%) | 983 (1.5%) |
Financial and Insurance Activities | 3991 | 2299 (3.3%) | 1692 (2.5%) |
Real Estate Activities | 1561 | 766 (1.1%) | 795 (1.2%) |
Professional, Scientific and Technical Activities | 3275 | 1715 (2.5%) | 1560 (2.3%) |
Support Service Activities | 3666 | 1825 (2.6%) | 1841 (2.7%) |
Public Administration and Defense | 2730 | 1337 (1.9%) | 1393 (2.1%) |
Education | 2116 | 1254 (1.8%) | 862 (1.3%) |
Human Health and Social Work Activities | 3215 | 1941 (2.8%) | 1274 (1.9%) |
Amusement and Recreation Activities | 1567 | 852 (1.2%) | 715 (1.1%) |
Other Service Activities | 11,662 | 6535 (9.4%) | 5127 (7.7%) |
Company size | |||
Shut down | 13,272 | 6300 (9.0%) | 6972 (10.4%) |
Small | 9994 | 5096 (8.1%) | 4898 (8.2%) |
Small and medium | 30,095 | 15,470 (24.4%) | 14,625 (24.5%) |
Large | 82,981 | 42,753 (67.5%) | 40,228 (67.3%) |
Pathological stage | |||
0 | 9165 | 7505 (24.4%) | 1660 (9.2%) |
1 | 14,586 | 10,307 (33.5%) | 4279 (23.8%) |
2 | 11,418 | 7588 (24.7%) | 3830 (21.3%) |
3 | 8372 | 4101 (13.3%) | 4271 (23.7%) |
4 | 5209 | 1261 (4.1%) | 3948 (22.0%) |
Cancer type | |||
Oral cavity | 12,222 | 5715 (8.2%) | 6507 (9.7%) |
Major salivary glands | 485 | 333 (0.5%) | 152 (0.2%) |
Nasopharyngeal | 4116 | 2388 (3.4%) | 1728 (2.6%) |
Esophagus | 2989 | 377 (0.5%) | 2612 (3.9%) |
Stomach | 4467 | 1530 (2.2%) | 2937 (4.4%) |
Small intestine | 463 | 222 (0.3%) | 241 (0.4%) |
Colon | 8118 | 3889 (5.6%) | 4229 (6.3%) |
Rectum and anus | 6348 | 3147 (4.5%) | 3201 (4.8%) |
Liver and intrahepatic bile ducts | 16,091 | 3733 (5.4%) | 12,358 (18.5%) |
Gallbladder and extrahepatic bile ducts | 743 | 190 (0.3%) | 553 (0.8%) |
Pancreas | 1579 | 132 (0.2%) | 1447 (2.2%) |
Posterior peritoneal cavity and peritoneum | 252 | 105 (0.2%) | 147 (0.2%) |
Nasal, middle ear and paranasal sinuses | 366 | 181 (0.3%) | 185 (0.3%) |
Larynx | 820 | 417 (0.6%) | 403 (0.6%) |
Lung, bronchi and trachea r | 9432 | 1525 (2.2%) | 7907 (11.8%) |
Thymus, heart and mediastinum | 664 | 310 (0.4%) | 354 (0.5%) |
Bone, joint and articular cartilage | 274 | 151 (0.2%) | 123 (0.2%) |
Connective tissue and other soft tissue | 830 | 440 (0.6%) | 390 (0.6%) |
Skin | 2935 | 2018 (2.9%) | 917 (1.4%) |
Female breast | 23,292 | 16,768 (24.1%) | 6524 (9.8%) |
Cervix | 13,708 | 11,048 (15.9%) | 2660 (4.0%) |
Uterus | 3174 | 2282 (3.3%) | 892 (1.3%) |
Ovary, fallopian tube and broad ligament | 2489 | 1380 (1.9%) | 1109 (1.7%) |
Prostate | 1647 | 802 (1.1%) | 845 (1.3%) |
Testis | 398 | 308 (0.4%) | 90 (0.1%) |
Bladder cancer | 2528 | 1476 (2.1%) | 1052 (1.6%) |
Kidney | 1532 | 857 (1.2%) | 675 (1.0%) |
Renal pelvis and other urinary structures | 1245 | 607 (0.9%) | 638 (0.9%) |
Eye and lacrimal gland | 144 | 90 (0.1%) | 54 (0.1%) |
Brain | 1169 | 364 (0.5%) | 805 (1.2%) |
Thyroid | 5439 | 4295 (6.2%) | 1144 (1.7%) |
Leukemia | 4618 | 1977 (2.8%) | 2641 (3.9%) |
Others | 605 | 337 (0.5%) | 268 (0.4%) |
